Imperative Care announced that it intends to fund a trial comparing its Zoom stroke system plus best medical treatment to ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

Imperative Care, Inc. will fund an independent, randomized clinical trial for the treatment of M2 occlusions in stroke patients.

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Catheter, the company ...

Symphony Thrombectomy System is designed to efficiently maximize clot removal with a focus on minimizing blood loss Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA ...